The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis
Parul Tandon(University of Ottawa), Jeffrey D. McCurdy(University of Ottawa), Simon Parlow(University of Ottawa), Kirles Bishay(University of Ottawa), Samuel Bourassa‐Blanchette(University of Ottawa), Scott A. Laurie(Ottawa Hospital)
Cited by 82
Related Papers
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
|The Lancet Oncology|2016|1.2k
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
|Journal of Clinical Oncology|2006|504
Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
|Journal of the American College of Cardiology|2019|398
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
|The Lancet Oncology|2010|394
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
|Journal of Clinical Oncology|2017|366